ARNOLD EHRET INNERTABS 295 MG
SENNA : 295 MG PLANTAGO SEED : 35 MG ALDER BUCKTHORN : 120 MG · DIN 00555614 · ALVIN LAST, INC.
Health Canada status: CANCELLED POST MARKET
What is ARNOLD EHRET INNERTABS?
ARNOLD EHRET INNERTABS 295 MG contains SENNA : 295 MG PLANTAGO SEED : 35 MG ALDER BUCKTHORN : 120 MG. It is listed in the Health Canada Drug Product Database under DIN 00555614, held by ALVIN LAST, INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 20-Feb-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00555614 |
|---|---|
| Brand name | ARNOLD EHRET INNERTABS |
| Generic / active ingredient | SENNA : 295 MG PLANTAGO SEED : 35 MG ALDER BUCKTHORN : 120 MG |
| Manufacturer | ALVIN LAST, INC. |
| Strength | 295 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AC51 ISPAGHULA, COMBINATIONS |
| AHFS class | 56:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 20-Feb-1997 |
| Original market date | 1959-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A06AC51 ISPAGHULA, COMBINATIONS. 0 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ARNOLD EHRET HERBAL LAXATIVE | 590 MG | POWDER | ALVIN LAST, INC. | CANCELLED POST MARKET | DIN 00555541 |
| FLORALAX | 2.8 G / 5 G | POWDER | FLORA MANUFACTURING AND DISTRIBUTING LTD. | CANCELLED POST MARKET | DIN 02246513 |
| HERBAL FIBRE 650 - CAP | 48.75 MG | CAPSULE | HEALTH-WISE NUTRITION INC. | CANCELLED POST MARKET | DIN 02177307 |
| MULTILAX 1 CAP | 378 MG | CAPSULE | NATURE'S WAY OF CANADA LTD. | CANCELLED POST MARKET | DIN 00629561 |
| PRODIEM PLUS | 542 MG | POWDER | NOVARTIS CONSUMER HEALTH CANADA INC. | CANCELLED POST MARKET | DIN 02162253 |
| PRODIEM PLUS POWDER | 542 MG | POWDER | RHONE-POULENC RORER CONSUMER INC. | CANCELLED POST MARKET | DIN 01937626 |
| SUPER FIBER BLEND | 2.330 G / 15 G | POWDER FOR SOLUTION | NUTRICAN NUTRITIONALS LTD. | CANCELLED POST MARKET | DIN 02241711 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.